Publication | Closed Access

Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein

VaccinationTumor ImmunologyCancer ImmunosurveillanceAnti-her2/neu Igg3-ImmunologyTumor ImmunityTherapeutic VaccineImmunologic MechanismAutoimmunityAnti-tumor ImmunityFusion ProteinImmunotherapyMedicineCell Biology